US Appeals Court Upholds Abortion Pill Restrictions, Pending Supreme Court Review

A federal appeals court has overturned a lower court's ruling that would have removed the medication abortion drug mifepristone from the market, but upheld aspects of the ruling that could limit access to the pills. The availability of mifepristone will not be affected for now, as the Supreme Court has already stated that the drug and its regulations will remain in place. This ruling is part of a significant legal battle over abortion rights since the Supreme Court's decision to overturn the Roe v. Wade precedent. Medication abortion is the most common type of abortion in the US, and the availability of abortion pills has been crucial in states where abortion is restricted. The lawsuit was filed by anti-abortion doctors and medical organizations, arguing that the FDA broke the law in approving mifepristone and relaxing certain restrictions.